IDUA and mucopolysaccharidosis type 1: Recently, comparisons of ICV, IT and intranasal (IN) delivery of AAV9 in MPSI mice demonstrated increased α-iduronidase (IDUA) activity in the brains of all treated mice compared to untreated controls.